Skip to main content

Table 4 Percent change from T0 in HORAC levels in clinical study

From: Acute reduction of serum 8-iso-PGF2-alpha and advanced oxidation protein products in vivo by a polyphenol-rich beverage; a pilot clinical study with phytochemical and in vitro antioxidant characterization

   % Change over T0
  T0 T60 T120 T180 T240
PRB 1 55.1 ±7.19* 67.5 ±7.20* 54.5 ±6.52* 75.8 ±9.21*
Placebo 1 23.6 ±5.38 74.7 ±5.91* 44.4 ±5.81* 43.0 ±8.47
  1. *p < 0.05 as compared to T0 by paired T-test.